A Film Nobody Believed In.
Bajrangbali Did.

Something is shifting in how India goes to the cinema.

Look at what's actually leading the chart this week — not what anyone expected to. A debut director's ₹2 crore devotional film with no stars. A streaming-show adaptation carried by character actors, not movie stars. Mandaadi, led by Soori — a comedian-turned-lead, not a conventional hero — outpacing a starrier rival on the same two days. And Haiwaan, built around two of Hindi cinema's biggest names reuniting for the first time since 2008, opening behind all of them.

None of that proves the star system is finished — Spider-Man and Practical Magic 2 are doing exactly what marquee names and franchises are supposed to do this same weekend in the US. But in India specifically, the pattern repeating across this chart, week after week this year, is hard to wave away as coincidence. Content and word of mouth are increasingly out-earning casting budgets. It's not a sudden collapse of the old model — it's a slow rerouting, one surprising opening at a time, and this weekend's Top 10 is as clean an example of it as any we've charted.

Hanuman Ansh isn't decaying. It's still climbing.

Every theatrical run is supposed to follow the same shape: open, peak, decay, exit. Hanuman Ansh broke that shape so early and so completely that nobody's models have a clean label for what it's doing now. This week gave us the clearest look yet at why.

Start with Week 2. ₹0.46 crore, on 25 shows nationwide at its lowest point. A film that small is supposed to quietly disappear from cinemas, not turn into a trade story. Nothing about a ₹0.46 crore week has a "normal decline" to interrupt, because there was no run left to decline from.

Then Week 3 did ₹9.96 crore, up 2,065%. Week 4 did ₹57.93 crore, up 482% — on expanding screens, not contracting ones. And Week 5 held at 97% of Week 4's total, while sharing cinemas with both Mirzapur and Toxic in the same seven days. Week 6's opening Friday alone brought in ₹10.50 crore — the kind of number most films would happily settle for on a random Tuesday, let alone a sixth Friday.

The Hollywood shape this actually resembles

It's rare, but not unheard of, for a film to break its own decay curve — rare enough that trade trackers usually name the ones that do. Obsession (2026), Focus Features' sleeper horror hit, is the closest recent comparable in the US market: it grew +39.3% in week 2 against an industry-standard 40–50% expected drop, then grew again, +19% in week 3. Box Office Watch, the film's own tracker, widened its prediction band after week 3 because the growth broke its own model.

The comparison is instructive precisely because the shapes differ. Obsession broke a well-understood rule — horror sequels are supposed to drop hard, and it grew instead. Hanuman Ansh doesn't have a rule to break, because nothing that falls to ₹0.46 crore in its second week is supposed to have a trajectory left at all. Both hit the same diagnostic moment — the point where a tracker's own model says "this should be falling and it isn't" — just from opposite starting conditions.

The India lifetime model

We're assuming Week 6 holds close to its current pace, Week 7 brings the first real pullback, and a long tail follows after that — the same plateau-then-decline shape that let Obsession and similar sleeper hits outrun their own early trajectories for a month or more before settling. At the midpoint, that's a lifetime return of roughly 196 times the film's production cost.

Who actually made this

A genuinely new team. Dr Vishal Chaturvedi, who wrote, directed and produced Hanuman Ansh, is making his feature film directorial debut. Before this, his 14-year career ran through content creation, cooking, research and entrepreneurship — he's the founder of The Indian Thing and Holy Cow Home Productions, not a studio-trained filmmaker. The film adapts his own book, Divine Detour: That Changed My Life.

Photos: TMDB, where available

The producing team is four people: Chaturvedi himself alongside Ragini Sona, Namrata G. Singh and Anupriya Nagar, working under his own banner, Swambhu Media Network, with no major studio behind it. No stars, barely any marketing spend — the entire trajectory from ₹10 lakh to ₹200 crore-plus has run on audience word of mouth alone.

Chaturvedi's own words to Variety India, on what the film's run means for other first-time filmmakers: "Every time a door closes, there's a bigger opportunity opening for you. You have to believe this. If you believe this, then one day you will hit that right point — that sweet spot."

Mirzapur is quietly heading toward blockbuster status, and the real story is what it proves.

Day 8: ₹9.50 crore. Cumulative worldwide: past ₹210 crore. On a ₹90 crore budget with a ~₹95 crore break-even, Mirzapur has been in profit since day four — and it's still outgrossing Haiwaan's entire opening day from a week-old position in its run.

Photos: TMDB, where available

Credit this run to the cast as much as the concept. Pankaj Tripathi, Ali Fazal, Divyenndu and Ravi Kishan carried three seasons of built-up trust straight from the streaming audience into cinema seats — none of them a conventional theatrical superstar, all of them the reason ticket buyers already knew exactly who Kaleen Bhaiya and Guddu Pandit were before a single trailer ran.

The gamble everyone doubted: taking a streaming show to cinemas

Mirzapur spent three seasons building its audience on Prime Video — a real cult following, but a streaming one, watched at home as part of a subscription people already had. Turning that into a paid theatrical release, with no film-original story and no single above-the-title superstar, was treated as a real risk when Amazon MGM and Excel Entertainment first announced it. Business Today called it exactly that: "an OTT gamble."

The gamble is paying off in a way that's setting a precedent rather than just clearing a bar. Bollywood Hungama's own framing: the film's run "underlines the growing appetite for established streaming properties to make the transition into cinema." It's one of the first Indian streaming series to attempt this jump at all — and it's outperformed two theatrical-original releases in the same window, Awarapan 2 and Welcome to the Jungle, with a cast the audience already knew from television, not from movie posters.

There's a second debut-director story buried in this one too. Gurmeet Singh, who directed 17 episodes of the original series, is making his own feature film directorial debut with this movie — the same pattern as Hanuman Ansh's Vishal Chaturvedi, a TV-trained storyteller stepping into cinema for the first time and immediately posting one of the year's biggest results.

And the strategy doesn't end at the multiplex: per Variety's original report on the deal, the film moves to Prime Video across 240 territories after an eight-week theatrical exclusivity window — meaning every rupee it earns in cinemas now is pure upside before it returns to the platform that built its audience in the first place.

Two of this week's three biggest films in India — Hanuman Ansh and Mirzapur — are both first features from directors who'd never made one before. That's not a coincidence worth ignoring. It's the same lesson twice: an audience will follow a story it trusts, regardless of who's credited as director or how much the poster cost to print.

The national Top 10 · September 12

Friday is settled across the board. Mandaadi and Sardar 2's Saturday figures are also real, confirmed via their own reported 2-day cumulatives. Hanuman Ansh, Mirzapur, Irumudi and Bethlehem Kudumba Unit's Saturday/Sunday are Boxoffy estimates. Ranked by projected weekend total.

*Rows marked "est" are modelled. Field weekend total: ~₹146 Cr.

Also released this weekend — outside the ranked field

Last Man in Tower opened the same day as Haiwaan — Manoj Bajpayee and Boman Irani, adapted from Aravind Adiga's novel, Rana Daggubati's first Hindi production. No trade tracker has published a figure for it anywhere; that silence is itself the signal. It reads as a narrow, festival-adjacent release rather than a wide commercial one, and it isn't competing for the same audience or the same screens as anything else in this chart. We'll add it once a real number exists rather than estimate one from nothing.

The US Top 10 · September 11–13

Two records are converging on the same weekend. Spider-Man: Brand New Day is closing in on the all-time domestic gross record, and Practical Magic 2 just posted Warner Bros.' strongest Thursday previews of 2026.

Resident Evil isn't in this frame — it opens September 18 — but it's already the loudest conversation in the trade press, tracking as high as $45–59M opening / $90–153M lifetime per aggregated industry boards. That's next week's story, arriving with real momentum behind it.

Drishyam: The Conclusion just posted a number worth checking twice.

The trailer dropped on Wednesday, September 9, and by Thursday it had crossed roughly 25 million views in 24 hours — the same territory Pathaan's trailer hit at the same mark, one of the biggest Hindi trailer debuts on record. For comparison, Prime Video's own Drishyam 2 final-scene clip sits at 9 million views after six full days. The trailer cleared that in under one.

What ₹50 Cr would actually require

Only two Hindi films have opened past ₹50 crore, and both needed serious national chain advance to get there: Dhurandhar: The Revenge (4.60 lakh tickets → ₹102.55 Cr) and Jawan (4.00 lakh Hindi tickets → ₹65 Cr). Drishyam would need 2.25–3.1 lakh tickets across PVR, INOX and Cinepolis by T-1 to make ₹50 Cr the base case rather than the ceiling — roughly double what Dhurandhar's original needed for its own ₹28 Cr open.

All-time Gandhi Jayanti openers: War (2019) at ₹53.35 Cr remains unbeaten. Bang Bang (2014) did ₹27.54 Cr, Gold (2018) did ₹25.25 Cr. Trade coverage this week projects Drishyam landing second on that list — past Bang Bang, short of War.

Recommendation for the makers: open general advance at T-14 (18 September) — the same window Singham Again used for Ajay Devgn's own biggest non-ensemble opening. The trailer has the heat. Converting it into national chain tickets over the next three weeks is the actual job from here.

OTT this week · new releases, holdovers, and the cross-platform chart

India still has no published weekly watch-time currency — Ormax reports viewers, not minutes, and does so quarterly. This index is a Boxoffy model built from platform trending position, runtime, theatrical performance and search interest. It's an estimate, not a measurement, and we say so every time we publish it.

September releases, India and US, at a glance

India — confirmed this month

Toxic, Awarapan 2 (closing), Hanuman Ansh (Week 5–6), Bethlehem Kudumba Unit, Irumudi, I'm Game, Mirzapur: The Movie, Haiwaan, Mandaadi, Sardar 2, Last Man in Tower. Hanuman Ansh's Telugu dub arrives September 18 via Trivikram Srinivas and Fortune Four Cinemas.

United States — confirmed this month

Practical Magic 2, Runner, Hope, The Uprising, Oasis: Don't Look Back in Anger — this weekend. Resident Evil (Sept 18) and Avengers: Endgame: Encore (Sept 25, a premium-format-only re-release carrying an exclusive Doomsday sneak peek) close out the month.

Quick answers

Have a correction, a tip, or verified box office data?

Studios, distributors and trade contacts — share verified figures directly and we'll cite you accurately. Readers — tell us what we got wrong.